We conducted a ret rospecti ve review of pathology f iles ' and hosp ital records and ident ified three unusual pr esentat ions of granulocy tic sarcoma associated with acut e myeloid leukemi a (AML) of the head and neck. At least one mass was obse rved on the skin ofall three patients. A 17-year-old boy had masses in each temp oral region that were accompanied by bilateral fa cial paralysis. He was administered chemo the rapy and rad iotherap y, bu t he died ofinfection seconda ry to a second relap se 29 months af ter the initia l dia gnosis. A i 7-yearold girl had a tum or in the right parotid area. She recei ved chemo therapy, but she died of infection and bleeding 2 month s aft er the initial diagnosis. A 33-ye ar-old man had num erous tumors widely disseminat ed over his skin. He received chemo therapy and was in remissio n i 2 month s aft er the initial diagnos is, but he eventually relap sed and died. Granulocyt ic sarcoma can be localized in unexp ected regions, including the head and neck. This tumor is very of ten misd iagnosed as a malignant lymphoma, which leads to dela yed treatm ent and a poor outcome. Therefo re, clinical and histopathologic fi ndings should be evaluated bef ore any diagnosis of malignant lymphoma is pronounced. imm unohistochemical stains sho uld also be perform ed on patients with suspected g ranulocytic sarcoma, and aggressive chemo the rapy or imm unotherapy should be administered. We believe that high-dose chemotherap y can imp rove survival rates in granulocy tic sarcoma associated with AML.
Introduction
A granulocy tic sarco ma is a rare, extramedulla ry, so lid aggregate of malig nant myeloid prec ursor cell s. The term granulocy tic sa rcoma wa s first used by Rapp aport in 1966.' Th is malignancy is also know n as a chloroma.
In this article, we descr ibe three unu su al present ations of gra nulocytic sarcoma that were associated with acute myeloid leukemia (A ML) . One patient had bilatera l faci al paraly sis ca used by tem poral bone involveme nt of bilatera l granulocytic sarcoma; we believe that thi s is the first such rep orted case in the literat ure . An ot her patient exhibited parotid gla nd invol vem ent; we determined tha t this is only the second such rep orted case . T he thi rd patient had 12 tum or s wide ly d issem inated ove r his skin; to our knowledge thi s is the first rep orted case in the literatur e. In addition to these case rep ort s, we also discu ss the clinica l beh avior , histopathology, trea tme nt, and prognosis of granulocytic sarco ma associated with AML of the head and neck reg ion .
Case reports
Pat ient 1. In Januar y 1996, a white 17-year-old boy was ad mitted to our hospit al with a 2-week history of weakness and feve r. On admission , the patie nt' s ge neral co ndition was poor. Physical examinatio n revea led pallor, diffuse petech ia and purpura, and hepatospl en om egaly. Morpho logic , cytoc he mica l, and immunocytochem ical stud ies confirme d the d iagnosis of AM L (M4-FAB) . He was adm inistered the standa rd chemo the rapeutic regimen for rem ission inductio n of AML.
After 2 1 month s of therapy, the patien t wa s rea dmitted because of a sudden onse t of bilateral facial par alysis, a sudde n hearin g loss, vision disturbance, and the appea rance of a firm, painful , rapidly grow ing mass in each of his postaur icu lar are as. Th e masses we re 7 and 5 ern in d iameter on the righ t and left , respecti vely; the sk in covering the two masses was nor mal. On co mputed tomograp hy (CT) , the masses co uld be see n in both The patient' s whit e blood cell count (WBC) was 150 x 109/L. An incision al biop sy of the mass in the right postauricular area was obtained, and the histop athologic examination revealed a highly cellular tumor. The patient was given a histopathologic diagnosis of granulocytic sarcoma (his first relapse) . At this time, leukemic cell s were observed in bone marrow. He was placed on a chemotherapeutic regimen of daunorubicin and cytosine arabinoside (ARA-C) for rem ission induction of AML.
Following chemotherapy, a CT examination found no evide nce of tumo r in either post auricular area, and the patient' s facial paralys is had subsided. Th e patient was then administered a 10-day regimen of radiotherapy (240 cGy/d ay) deli vered to both temporal region s.
Two month s later, the patient experienced a second relap se and his condition deteriorated . Leuk emic cells were observ ed in the periph eral smear and in bone marrow . Furth er induction chemotherapy was planned, but the patient died of infection befor e it could be initiated. His death came 2 years and 5 months after the initial diagnosis. An autopsy was not performed.
Patient 2. In Jun e 1998, a white l7-year-old girl was admitted to our hospital with a 3-month history of abdominal pain , right preauri cular swelling, weight loss, and weakne ss. On admi ssion, her general condition was poor, and her physical examination showed pallor and an ill-defined soft mass measurin g 5 ern in diameter in the right preauricul ar area; the skin coverin g the mass was erythematous. In additi on, bilate ral cervical and submandibular lymphadenopathy and hepatosplenomeg aly were observed.
The patient ' s WBC, platelet, and hemoglobin levels were 3.5 x 109/L, 17 x 109/L, and 8 g/dl , respectively . Mo rpholo gic, cytochemical, and immunocytoch emical studies, includ ing peripheral smear and bone marro w aspiration analyses, confirmed the dia gno sis of AML (M4-FAB). Ultrasonographic examination showed that the right parotid gland and its covering skin had been infiltrated by tumor ( figure 2 ). Fine-ne edl e aspiration biopsy of the mass revealed that the tumor cells were imm ature blast form s. The cy topathologic dia gno sis was gra nulocytic sarcoma . The patient was adminis tered the standa rd chemotherapeutic regimen for rem ission induction of AML.
Evaluation on day 28 following the cessation of chemotherapy showed no remi ssion , and the marrow aspiration and biopsy showed more than 5% blast s. However, no ev idence of tumor was noted in the right preaur icular area on ultrasonographic ex amin ation, and no blast was detected in the peripheral smear. Taken togeth er, these findings were con side red to represent a partial remission, and a course of reinduction chemotherapy was planned. However, the patient refused a second round of therapy.
One month later, she was readmitted to the hospital in poor conditi on. Her per ipheral smear show ed 80% blasts. Ten days later , she died of infection and bleed ing. An autopsy was not performed.
Patient 3. In December 1997, a white 33-year-old man was admitted to the hospit al with a 4-m onth history of multiple masses on his skin. A previou s skin biop sy had been misdiagn osed by the pathologist as a malignant lymphoma, and the patient had undergon e three courses of che motherapy . When his general condition had not impro ved and his masses had not disappe ared , he returned to seek further treatment. On admi ssion , the patient ' s general condition was poor. Physical examination showed fever, bilateral cervical and axillary lymphadenopath y, and splenomegaly. Th e skin was marked by 12 soft, tender, nonulc erated, and viol aceou s nodul es, which varied in diameter from 4 to 12 cm (figure 3).
The patient' s WBC , platelet , and hem oglobin levels were 150 x 109/L, 60 x 109/L, and 6 g/dl, respectively.
Ever shave with a dull blade?
Ever been handed a dull curette?
Don't you just hate that?
Disposable Adenoid Curettes. Never "do" dull again.
New Dis posable Adenoid Curettes are the only disposable aden oid curettes available. They are desig ned to look and feel like a standard Barnhill -type adenoid curett e, but offer a reliably s harp edge for every case . A variety of sizes offers the prope r fit for variations in anatomy and is affordable for every bud get. 
: Multiple violaceous nodules appear on the skin ofa 33-year-old man. A : Single masses appear on the lateral aspect ofthe right (thin arrow) and left (wide arrow i flanks, and two masses on the lower right back. B : Two masses appear on the anterior aspect ofthe left thigh and one each on the medial aspect ofthe left leg, the lateral aspect ofthe left thigh (thin arrow), the medial aspect of the right thigh (wide arrow) , and the posterior aspect of the left leg. C: Tumor tissue analysis reveals large, immature mononu clear cells with one or two promin ent nucl eoli and immature nuclear chromatin patterns (H&E, original magnification X 100).
Bone marrow asp iration detected 85 % monoblasts. Morphologic, cytochemical, and immunocytochemical studies confirmed the diagnosis of AML (M5A-FAB). An incisional biopsy of the tumor showed that the tissue was made up of large immature mononuclear cells, which featured high nuclear-cytoplasmic ratio s and immature nuclear chromatine patterns ( figure 3) . The nuclei were round to oval and had one or two prominent nucleoli. The histopathologic diagnosis was gr anulocytic sarcoma. The patient was placed on the standard chemotherapeutic regimen for remission induction of AML.
Evaluation on day 26 following the cessation of remission-induction therapy showed no remission. The patient's lesions were smaller, but they had not dis appeared. He was therefore administered reinduction chemotherap y, which consisted of daunorubicin , etoposide, and ARA-C.
Evaluation on day 28 following reinduction therapy showed that the patient's masses had disappeared and that . he was in remission. Two identical courses of reinduction chemotherapy were then given for consolidation.
By August 1998 , the patient was still in remission and an allogenic peripheral stem cell transplant wa s suggested. However, the patient could not afford this treatment, so postconsolidation immunotherapy with interleukin-2 was initiated instea d. However, 3 months later he rel apsed and died.
Discussion
Granulocytic sarcoma usually involves the bone, soft tissue, lymph nodes , and skin.' It rarely involves the parotid area.' Although leukemic infiltration of the temporal bone is seen occasionally , symptomatic facial ne rve involvement is extremely rare, even in patients with granulocytic sarcoma." Through January 2001, only three 228 cases of unil ateral facial paralysis secondary to temporal bone invol vement of unilateral granulocytic sarc oma associ ated with AML have been reported in the Engli shlanguage literature." ? To our knowledge, our case represents the first report of bilateral paraly sis. Involvement of the parotid gland is extremely rare in granulocy tic sarcom a asso ciated w ith AML; as far as we know , onl y one other case has been reported in the Engli sh-language literature.'
Granulocytic sarcoma usu ally develops before or during the course of myeloid leukemia." One of our cases (patient I) was di agnosed as granulocytic sarcoma 2 years after the AML diagnosis. The other two pati ent s were diagnosed with granulocytic sarcoma after they had been admitted to the ho spital.
There are three type s of skin involvement in AML: nonspecific lesions," leukemi a cut is," and granulocytic sarcoma.v' T he mo st common initi al sy mptoms in patient s with temporal bone involvement are postauricular aching and swelling, he aring loss , otalgia, and tinnitus.v!' Faci al and acoustic nerve paralysis can subsequently develop as a result of a perineural and/or men ingeal leukemic infiltration associ ated with hemorrhage, edema, or an ad ver se reaction to drug therapy ." One of our patients (patient I) had bilateral temporal bone invol vement, bil ateral facial paralysis, hearing loss , and vision disturbance.
Histochemical and immunohistochemica l techniques allow for a conclusive dia gno sis of granulocytic sarcoma, even with routinely processed paraffin-embedded material ." Histopathologicall y, thi s diagnosis is often difficult to make in patients who do not have acute leukemia. As many as 75 % of these tumors are initially mi sdiagnosed , most as malignant lymphoma.t' :" This is precisel y what had happened in one of our three ca ses (patient 3).
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Patients with granulocytic sarco ma associated with AML have a poor pro gnosis. " Patients are routine ly treated with chemotherapy , with or without radiotherapy . but as man y as 85 % re lapse within I yea r." Therefor e, the defi niti ve tre atment should be chemo therapy followed by hem atopoietic stem cell tran sp lant ation . When tran sp lantation is not possib le, we bel iev e that chemotherapy might still improve survival rates if it is admini stered in higher do ses than usual.
